208 related articles for article (PubMed ID: 10873434)
1. Antibacterial activity of flavonoids against methicillin-resistant Staphylococcus aureus strains.
Alcaráz LE; Blanco SE; Puig ON; Tomás F; Ferretti FH
J Theor Biol; 2000 Jul; 205(2):231-40. PubMed ID: 10873434
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial effect of octylcyanoacrylate against methicillin-resistant Staphylococcus aureus isolates from patients with chronic suppurative otitis media.
Jang CH; Park H; Choi CH; Cho YB; Park IY
In Vivo; 2008; 22(6):763-5. PubMed ID: 19181004
[TBL] [Abstract][Full Text] [Related]
3. Effect of certain bioactive plant extracts on clinical isolates of beta-lactamase producing methicillin resistant Staphylococcus aureus.
Aqil F; Khan MS; Owais M; Ahmad I
J Basic Microbiol; 2005; 45(2):106-14. PubMed ID: 15812867
[TBL] [Abstract][Full Text] [Related]
4. Flavonoids with activity against methicillin-resistant Staphylococcus aureus from Dalea scandens var. paucifolia.
Nanayakkara NP; Burandt CL; Jacob MR
Planta Med; 2002 Jun; 68(6):519-22. PubMed ID: 12094295
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
6. Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus.
Liu XL; Xu YJ; Go ML
Eur J Med Chem; 2008 Aug; 43(8):1681-7. PubMed ID: 18031869
[TBL] [Abstract][Full Text] [Related]
7. Emergence and spread of low-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from a community hospital in Japan.
Watanabe H; Masaki H; Asoh N; Watanabe K; Oishi K; Furumoto A; Kobayashi S; Sato A; Nagatake T
J Hosp Infect; 2001 Apr; 47(4):294-300. PubMed ID: 11289773
[TBL] [Abstract][Full Text] [Related]
8. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
Dolapçi I; Karahan ZC; Tekeli A; Koyuncu E; Azap A; Adaleti R
Mikrobiyol Bul; 2007 Jul; 41(3):435-40. PubMed ID: 17933255
[TBL] [Abstract][Full Text] [Related]
9. Cationic chalcone antibiotics. Design, synthesis, and mechanism of action.
Nielsen SF; Larsen M; Boesen T; Schønning K; Kromann H
J Med Chem; 2005 Apr; 48(7):2667-77. PubMed ID: 15801857
[TBL] [Abstract][Full Text] [Related]
10. The effects of antibiotics combined with natural polyphenols against clinical methicillin-resistant Staphylococcus aureus (MRSA).
Lin RD; Chin YP; Hou WC; Lee MH
Planta Med; 2008 Jun; 74(8):840-6. PubMed ID: 18546080
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial activity of chalcones, hydrazones and oxadiazoles against methicillin-resistant Staphylococcus aureus.
Moreira Osório T; Delle Monache F; Domeneghini Chiaradia L; Mascarello A; Regina Stumpf T; Roberto Zanetti C; Bardini Silveira D; Regina Monte Barardi C; de Fatima Albino Smânia E; Viancelli A; Ariel Totaro Garcia L; Augusto Yunes R; José Nunes R; Smânia A
Bioorg Med Chem Lett; 2012 Jan; 22(1):225-30. PubMed ID: 22169259
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial action of anacardic acids against methicillin resistant Staphylococcus aureus (MRSA).
Kubo I; Nihei K; Tsujimoto K
J Agric Food Chem; 2003 Dec; 51(26):7624-8. PubMed ID: 14664518
[TBL] [Abstract][Full Text] [Related]
14. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Micek ST
Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
[TBL] [Abstract][Full Text] [Related]
15. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary relationships between sporadic and epidemic strains of healthcare-associated methicillin-resistant Staphylococcus aureus.
Hallin M; Denis O; Deplano A; De Ryck R; Crèvecoeur S; Rottiers S; de Mendonça R; Struelens MJ
Clin Microbiol Infect; 2008 Jul; 14(7):659-69. PubMed ID: 18558938
[TBL] [Abstract][Full Text] [Related]
17. Quercus infectoria: a candidate for the control of methicillin-resistant Staphylococcus aureus infections.
Chusri S; Voravuthikunchai SP
Phytother Res; 2008 Apr; 22(4):560-2. PubMed ID: 18338770
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of heterogeneous methicillin-resistant Staphylococcus aureus (MRSA) among the MRSA clinical isolates in a Japanese university hospital.
Kishii K; Ito T; Watanabe S; Okuzumi K; Hiramatsu K
J Antimicrob Chemother; 2008 Aug; 62(2):324-8. PubMed ID: 18467309
[TBL] [Abstract][Full Text] [Related]
19. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report.
Orrett FA
Jpn J Infect Dis; 2008 Mar; 61(2):107-10. PubMed ID: 18362397
[TBL] [Abstract][Full Text] [Related]
20. In vitro antimicrobial activity of telavancin against methicillin-resistant Staphylococcus aureus clinical isolates from Japan (2006).
Hatano K; Matsuzaki K; Sato Y; Kobayashi I; Yamaguchi K
J Antibiot (Tokyo); 2007 Nov; 60(11):709-12. PubMed ID: 18057701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
